Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03616028 · ClinicalTrials.gov registry record · NA
The CONFORMAL Early Feasibility Study
A NA study of Non-valvular Atrial Fibrillation, sponsored by Conformal Medical.
- Active
- Registry status
- NA
- Development phase
- 64
- Enrollment target
- 11
- Study locations
NCT03616028 is a NA study of Non-valvular Atrial Fibrillation that is active but no longer recruiting, run by Conformal Medical. The registered enrollment target is 64 participants. The trial reports 11 study locations across 8 states.
The verdict
NCT03616028, a NA study of Non-valvular Atrial Fibrillation, is active but no longer recruiting, sponsored by Conformal Medical.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 64 participants
- Enrollment target
- 11
- Study locations
Study Summary
An evaluation of the safety and performance of the Conformal Left Atrial Appendage Seal for Left Atrial Appendage Occlusion
Conditions Studied
Interventions
- DEVICE left atrial appendage closure
Study Locations (11)
New York
- Mount Sinai - New York
- Columbia University Medical Center/NYPH - New York
Tennessee
- Erlanger Health System - Chattanooga
- Vanderbilt University Medical Center - Nashville
Texas
- Texas Cardiac Arrhythmia Institute - Austin
- Baylor Scott & white Research Institute - Plano
Arkansas
- St. Bernards Medical Center - Jonesboro
California
- Pacific Heart Institute - Santa Monica
New Hampshire
- Catholic Medical Center - Manchester
Ohio
- The Christ Hospital - Cincinnati
Pennsylvania
- Lankenau Heart Institute - Wynnewood
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 64 participants |
| Start Date | 2019-02-22 |
| Est. Completion | 2028-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03616028
The ClinicalTrials.gov registry entry for NCT03616028 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 64 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Conformal Medical, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Non-valvular Atrial Fibrillation appearing as the primary indexed condition, and to 1 intervention - of which left atrial appendage closure is the first listed.
NCT03616028 reports 11 study locations spanning 8 distinct geographic areas - top geographies include New York, Tennessee, Texas.
Frequently Asked Questions
What is clinical trial NCT03616028 about?
NCT03616028 is a clinical study titled "The CONFORMAL Early Feasibility Study". An evaluation of the safety and performance of the Conformal Left Atrial Appendage Seal for Left Atrial Appendage Occlusion
What is the current status of trial NCT03616028?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 64 participants. The study started on 2019-02-22. Estimated completion is 2028-06.
What conditions does trial NCT03616028 study?
This clinical trial studies the following conditions: Non-valvular Atrial Fibrillation.
What interventions are being tested in trial NCT03616028?
The interventions under investigation include: left atrial appendage closure (DEVICE).
Who is sponsoring clinical trial NCT03616028?
This trial is sponsored by Conformal Medical, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03616028 being conducted?
This trial has 11 study locations across Arkansas, California, New Hampshire, New York, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Non-valvular Atrial Fibrillation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.